MARKET

ZEAL

ZEAL

Zealand
NASDAQ

Real-time Quotes | Nasdaq Last Sale

31.89
+0.73
+2.36%
Closed 16:00 12/13 EST
OPEN
31.76
PREV CLOSE
31.16
HIGH
31.89
LOW
31.52
VOLUME
5.16K
TURNOVER
--
52 WEEK HIGH
36.84
52 WEEK LOW
11.56
MARKET CAP
1.15B
P/E (TTM)
-13.5199
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ZEAL and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ZEAL News

  • Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
  • GlobeNewswire.2d ago
  • Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
  • GlobeNewswire.2d ago
  • Zealand Pharma announces amendments to its Articles of Association following the granting of warrants
  • GlobeNewswire.5d ago
  • Financial calendar for Zealand Pharma in 2020
  • GlobeNewswire.5d ago

More

Industry

Biotechnology & Medical Research
+1.07%
Pharmaceuticals & Medical Research
-0.32%

Hot Stocks

Name
Price
%Change

About ZEAL

Zealand Pharma A/S is a Denmark-based biopharmaceutical company engaged in the discovery, development and commercialization of peptide-based medicines. The Company's pipeline comprises two implementation areas: Cardio-metabolic diseases and Other indications. The Cardio-metabolic diseases area includes medicines for diabetes and obesity treatment, such as Lyxumia (Lixisenatide), Lyxumia/Lantus, ZP2929 and Danegaptide. The Other indications area offers ZP1848, Elsiglutide and ZP1480 (ABT-719) drugs for inflammatory bowel disease, chemotherapy-induced diarrhea and acute kidney injury treatment. Furthermore, the Company collaborates with a number of partners, such as Sanofi, Helsinn, Boehringer Ingelheim, Abbvie and Eli Lilly.
More

Webull offers Zealand Pharma Aktieselskabet (ZEAL) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.